Skip to main content
Embecta Corp. (EMBC)
NASDAQ: EMBC · IEX Real-Time Price · USD
10.31
-0.09 (-0.87%)
Apr 26, 2024, 4:00 PM EDT - Market closed

Embecta Revenue

Embecta had revenue of $1.12B in the twelve months ending December 31, 2023, with 0.58% growth year-over-year. Revenue in the quarter ending December 31, 2023 was $277.30M with 0.58% year-over-year growth. In the fiscal year ending September 30, 2023, Embecta had annual revenue of $1.12B, a decrease of -0.77%.

Revenue (ttm)
$1.12B
Revenue Growth
+0.58%
P/S Ratio
0.53
Revenue / Employee
$510,182
Employees
2,200
Market Cap
593.64M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Sep 30, 20231.12B-8.70M-0.77%
Sep 30, 20221.13B-35.80M-3.07%
Sep 30, 20211.17B79.80M7.35%
Sep 30, 20201.09B-23.50M-2.12%
Sep 30, 20191.11B--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Cross Country Healthcare 2.02B
Fulgent Genetics 289.21M
SI-BONE 138.89M
Quanterix 122.37M
Zymeworks 76.01M
Revenue Rankings

EMBC News

More News